IV Bags Market Size, Share, Opportunities, And Trends By Material Type (PVC, PP, PE), By Capacity (Less Than 100 Ml, 100-250 Ml, 250-500 Ml, 500-1000 Ml, Above 1000 Ml), By Chamber Type (Single Chamber, Multi-Chamber), By End User (Blood Banks, Hospitals, Ambulatory Services), And By Geography - Forecasts From 2025 To 2030

The IV Bags market is projected to grow from US$4.312 billion in 2025 to US$5.677 billion in 2030 at a CAGR of 5.66%.

IV bags are pouches containing fluids, electrolytes, vitamins, minerals, and glucose solutions among others which are used in administering necessary fluids and nutrients in the body. The demand for IV packs is witnessing positive growth fueled by the growing electrolyte depletion, lack of hydration, and malnutrition problems in individuals which has bolstered the need for liquid nutrients and alternatives to be injected into the human body. 

Furthermore, IV packs are becoming progressively prevalent and favored alternatives for parenteral bundling due to their simple accessibility. The cost of an IV sack is roughly $1, which significantly contributes to the market's rising deals.

Moreover, car crashes are one of the leading causes of disability and death worldwide, resulting in up to 50 million injuries and 1.3 million fatalities annually.  Across the globe, one in every four deaths is related to walking or bicycling, based on the World Health Organization.  Fluid administration is therefore required due to the rising number of surgeries and accidents, which is anticipated to spur market expansion.

What are the IV Bags Market drivers?

• Growing chronic disease prevalence is propelling the market demand. 

Factors such as the rising prevalence of chronic diseases, the increased number of surgeries and road accidents, and the growing geriatric population are expected to drive market growth during the forecast period. For instance, according to the National Institute of Health in July 2022 stated that around 20% of individuals in western locales, such as North America and Europe, have gastroesophageal reflux illness (GERD) as of 2022. Besides, the predominance of GERD in the US extended from 18.1% to 27.8%

Furthermore, information from the Cancer Realities and Figures 2023 report demonstrates that 297,790 ladies in the US are expected to get an obtrusive breast cancer conclusion in 2023, up from 287,850 modern cases in 2022. Additionally, the same source states that in 2023, compared to 51,400 cases in 2022, approximately 55,720 women in the US are anticipated to receive a non-invasive (in situ) breast cancer diagnosis. Since cancer treatment deprives the body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, it is anticipated that the demand for IV bags will increase. It increases the need for patients to receive parenteral nutrition, which drives market expansion.

IV Bags Market Restraints:

• Plastic usage in producing IV bags can act as an obstacle to market growth 

IV bags are made of plastic materials such as polyvinyl chloride (PVC), and polypropylene (PP) among other materials. The decomposition rate of such materials is extremely low thereby making them hazardous for the environment, and with the growing healthcare concern followed by booming medical waste generation, the demand for such materials is expected to slow down shortly, which can limit the scale of IV bags production. 

However, with the ongoing shift towards sustainable materials and biocompatibility, various innovations are being made in healthcare equipment which will steadily propel the market demand and supply for IV bags having high bio-content.   

Segment analysis of IV Bags Market:

• Hospitals, based on end-user will account for a considerable market share.  

By end-users, the hospital is anticipated to constitute a significant market share fueled by the growing need for effective hospital administration for treating chronic diseases. Increasing cancer surgeries as well as organ transplant procedures also demand infusing intravenous fluids both during and after the completion of transplant surgery, which will lead to the growth of IV bags in the hospital sector in the coming years. As per Health Resources & Services Administration, organdonor.gov, the transplant performed by organs in the U.S. of kidney, liver, pancreas, heart, and lungs were 27,332, 10,660, 102, 812, and 4,545 respectively, as of March 2024. Additionally, Increasing launches of new products and approvals from the regulatory bodies also drive the growth of the market.

The demand for IV bags in hospitals will increase with the growing aging population, and rise in the prevalence of chronic diseases. Additionally, rising product launches and recycling drives of IV bags collected from hospitals across the country also drive the market for IV bags.

For instance, in December 2023, Baxter International completed the initial phase of its intravenous bag recycling program pilot for U.S. hospitals, partnering with Northwestern Medicine in Chicago. Over six tons of PVC IV bag waste were diverted from landfills for recycling.  Similarly, in February 2023, NUH, a large tertiary hospital in Singapore, initiated Singapore's first IV fluid bag recycling drive. 

What are the key geographical trends shaping the IV Bags Market:

• North America will continue to be the dominant market shareholder during the forecast period.

Geographically, the IV bags market has been segmented into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. 

During the forecast period, the North American region is estimated to hold a considerable market share fueled by the growing chronic disease prevalence in the major regional economies, followed by well-established healthcare infrastructure and an increase in the number of surgical procedures and hospital visits. According to the American Hospital Association, in 2022, the strength of hospitals in the United States stood at 6,129, whereas the total number of admissions in U.S. hospitals reached 34,011,386. 

Likewise, the increase in the prevalence of surgical procedures has also propelled the market demand, for instance, according to the American Society of Plastic Surgeons, in 2023, the total number of surgical procedures reported was 1,575,244 which signified a 5% growth over figure reported in 2022. Additionally, as per the data provided by the Alberta government, in 2022, the total number of surgeries conducted stood at 292,500 which represented a 13,900 increase over the preceding year’s surgical volume. 

Recent development in the IV Bage Market:

• In December 2024: Endo Inc. launched its ready-to-use pre-mix epinephrine premixed intravenous (IV) bag “ADRENALIN” which is FDA-approved and features advancements in patient deliveries thereby minimizing the risk of medication error.  The product extends Endo’s “TruDelivery” product line which is ideal for patient monitoring applications in hospitals and other healthcare facilities. 

IV Bags Market Scope:

Report Metric	Details
IV Bags Market Size in 2025	US$4.312 billion
IV Bags Market Size in 2030	US$5.677 billion
Growth Rate	CAGR of 5.66%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Material Type Capacity Chamber Type End-User Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in IV Bags Market	Sippex Kraton Corporation Renolit Solmed Alfa Laboratories Polycine GmbH
Customization Scope	Free report customization with purchase

The IV Bags Market is analyzed into the following segments:

• By Type
  • PVC
  • PP
  • PE
• By Capacity
  • Less than 100 ml
  • 100-250 ml
  • 250-500 ml
  • 500-1000 ml
  • Above 1000 ml
• By Chamber Type
  • Single Chamber
  • Multi-Chamber
• By End-User
  • Blood Banks
  • Hospitals
  • Ambulatory Services
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. CXO Perspective

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View 

5. IV BAGS MARKET BY TYPE

5.1. Introduction

5.2. PVC

5.3. PP

5.4. PE

6. IV BAGS MARKET BY CAPACITY

6.1. Introduction

6.2. Less than 100 ml

6.3. 100-250 ml

6.4. 250-500 ml

6.5. 500-1000 ml

6.6. Above 1000 ml

7. IV BAGS MARKET BY CHAMBER TYPE

7.1. Introduction

7.2. Single Chamber

7.3. Multi-Chamber

8. IV BAGS MARKET END-USER

8.1. Introduction

8.2. Blood Banks

8.3. Hospitals

8.4. Ambulatory Services

9. IV BAGS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. By Type

9.2.2. By Capacity

9.2.3. By Chamber Type

9.2.4. By End-User

9.2.5. By Country

9.2.5.1. USA

9.2.5.2. Canada

9.2.5.3. Mexico

9.3. South America

9.3.1. By Type

9.3.2. By Capacity

9.3.3. By Chamber Type

9.3.4. By End-User

9.3.5. By Country

9.3.5.1. Brazil

9.3.5.2. Argentina

9.3.5.3. Others

9.4. Europe

9.4.1. By Type

9.4.2. By Capacity

9.4.3. By Chamber Type

9.4.4. By End-User

9.4.5. By Country

9.4.5.1. Germany

9.4.5.2. France

9.4.5.3. United Kingdom

9.4.5.4. Spain

9.4.5.5. Others

9.5. Middle East and Africa

9.5.1. By Type

9.5.2. By Capacity

9.5.3. By Chamber Type

9.5.4. By End-User

9.5.5. By Country

9.5.5.1. Saudi Arabia

9.5.5.2. Israel

9.5.5.3. Others

9.6. Asia Pacific

9.6.1. By Type

9.6.2. By Capacity

9.6.3. By Chamber Type

9.6.4. By End-User

9.6.5. By Country

9.6.5.1. China

9.6.5.2. Japan

9.6.5.3. South Korea

9.6.5.4. India

9.6.5.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Sippex

11.2. Kraton Corporation

11.3. Renolit Solmed

11.4. Alfa Laboratories

11.5. Polycine GmbH

11.6. Haemotronic S.P.A.

11.7. Hospira Inc.

11.8. Technoflex S.A.

11.9. The Metrix Company

11.10. Medicopack A/S

11.11. Wipak Group

11.12. Qosina Corporation

Sippex

Kraton Corporation

Renolit Solmed

Alfa Laboratories

Polycine GmbH

Haemotronic S.P.A.

Hospira Inc.

Technoflex S.A.

The Metrix Company

Medicopack A/S

Wipak Group

Qosina Corporation